CUAMC
SGMO

China Universal Asset Management Company’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

China Universal Asset Management Company’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,546
Closed -$2.73K – 476
2023
Q3 		$2.73K Buy
4,546
+2,294
+102% +$2.46K ﹤0.01% 420
2023
Q2 		$2.93K Sell
2,252
-31
-1% -$42 ﹤0.01% 407
2023
Q1 		$4.02K Buy
2,283
+618
+37% +$1.76K ﹤0.01% 390
2022
Q4 		$5.23K Buy
1,665
+199
+14% +$772 ﹤0.01% 295
2022
Q3 		$7K Buy
+1,466
New +$7.53K ﹤0.01% 237

Other funds holding SGMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

China Universal Asset Management Company's SGMO Position: Q4 2023 in Review

China Universal Asset Management Company sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2023, closing a stake of 4,546 shares — an estimated $2.73K sold.

China Universal Asset Management Company first reported a position in SGMO in Q3 2022 and held it in 5 quarters. The position peaked at $7K in Q3 2022. 130 funds tracked by Wall St. Rank hold SGMO as of Q4 2023.

  • China Universal Asset Management Company reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2023 after selling out during the quarter.
  • China Universal Asset Management Company sold 4,546 SANGAMO THERAPEUTICS INC shares in Q4 2023, an estimated $2.73K.
  • China Universal Asset Management Company first reported a position in SANGAMO THERAPEUTICS INC in Q3 2022 and held it in 5 quarters.
  • China Universal Asset Management Company's SANGAMO THERAPEUTICS INC position peaked at $7K in Q3 2022.
  • 130 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2023.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.